Hosted on MSN6mon
Why Jennifer Doudna is one of Fast Company’s 10 most innovative people of the last 10 yearsThis story is part of a special series celebrating the 10th anniversary of the Fast Company Innovation Festival. When biochemist Jennifer Doudna and her research partner, Emmanuelle Charpentier ...
Ten years ago, Emmanuelle Charpentier and Jennifer Doudna published the study that paved the way for a new kind of genome editing: the suite of technologies now known as CRISPR. Writing in Science, ...
CRISPR leaders came together to celebrate the one-year anniversary of the Danaher-IGI Beacon for CRISPR Cures collaboration, ...
Hosted on MSN2mon
‘Much-needed hope’ as CRISPR gene editing therapy recommended for sickle cell diseaseThe discovery of the CRISPR/Cas9 gene editing tool won two researchers, Emmanuelle Charpentier and Jennifer A. Doudna, the Nobel Prize in Chemistry in 2020. Exa-cel, also called Casgevy ...
Her Doudna Lab team at Berkeley has also corrected the genetic mutation that causes sickle cell disease using CRISPR-Cas9. Some scientists warn about the ethical dangers of using gene editing in ...
In 2020, American biochemist Jennifer Doudna and French microbiologist Emmanuelle Charpentier were awarded the Nobel Prize in Chemistry for their discovery of the CRISPR gene-editing technology.
Researchers using CRISPR-Cas9 gene editing tools have discovered that while this technology can enhance T cell cancer therapies, it may also lead to unintended chromosomal loss in the edited immune ...
10monon MSN
Then came the discovery of Crispr gene editing, a tool for rewriting DNA with unprecedented speed and accuracy. Readers of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results